Rchr
J-GLOBAL ID：200901061421615958
Update date: Apr. 08, 2024
Kusumoto Shigeru
クスモト シゲル | Kusumoto Shigeru
Affiliation and department：
Job title：
Chief
Research field (1)：
Hematology and oncology
Research keywords (4)：
悪性リンパ腫
, Hematopoietic stem cell transplantation
, HBV再活性化
, 多発性骨髄腫
Research theme for competitive and other funds (4)：
- 2020 - 2023 がん化学療法後のB型肝炎ウイルス再活性化後の核酸アナログ中止規準の確立
- 2016 - 2020 Elucidation of mechanism of HBV reactivation associated with mogamulizumab-containing chemotherapy
- 2012 - 2015 Risk factor and mechanism of reactivation of hepatitis B virus following systemic chemotherapy
- 2008 - 2010 Identification of effective supportive care for cancer patients undergoing chemotherapy on evidence-based QOL assessment
Papers (192)：
-
Keiichiro Fujii, Atsushi Inagaki, Ayako Masaki, Mariko Sugiura, Tomotaka Suzuki, Takashi Ishida, Shigeru Kusumoto, Shinsuke Iida, Hiroshi Inagaki. Nomogram for predicting survival of patients with diffuse large B-cell lymphoma. Annals of hematology. 2024
-
Masahiro Onozawa, Shigeru Kusumoto, Yuho Najima, Hiroya Hashimoto, Kohei Okada, Masaharu Tamaki, Masatsugu Tanaka, Takayuki Sato, Tsutomu Takahashi, Kaoru Hatano, et al. Outcomes of cessation of the administration of nucleos(t)ide analogues on HBV reactivation after allogeneic hematopoietic stem cell transplantation: A nationwide retrospective study. Transplantation and cellular therapy. 2024
-
Kentaro Hirade, Shigeru Kusumoto, Hiroya Hashimoto, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, et al. Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer medicine. 2024
-
Hiroaki Hiramatsu, Rui Yokomori, Liu Shengyi, Norio Tanaka, Seiichi Mori, Kazuma Kiyotani, Osamu Gotoh, Shigeru Kusumoto, Nobuaki Nakano, Youko Suehiro, et al. Clinical landscape of TP73 structural variants in ATL patients. Leukemia. 2023
-
海老名 徹, 鈴木 智貴, 西垂水 希美, 近藤 明希, 中西 陽子, 加藤 佑希康, 松永 尚大, 丸茂 義晃, 浅野 有彩, 木下 史緒理, et al. 骨髄腫治療における、有害事象によるカルフィルゾミブ早期中止. 日本血液学会学術集会. 2023. 85回. 642-642
ｍore...
MISC (62)：
-
Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, et al. Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2022. 140. 11890-11892
-
丸山 大, 鏡味 良豊, 柴田 大朗, 飛内 賢正, 山本 一仁, 今泉 芳孝, 内田 俊樹, 島田 和之, 皆内 康一郎, 福原 規子, et al. 大量化療前導入治療R-CHOP-14とR-CHOP-14/CHASERの比較試験 JCOG0908(R-CHOP-14 vs. R-CHOP-14/CHASER induction prior to HDT in poor-risk untreated DLBCL: JCOG0908). 臨床血液. 2018. 59. 9. 1556-1556
-
飯田 真介, 丸山 大, 小川 岳人, 楠本 茂, 福原 傑, 福原 規子, 瀬尾 幸子, 宮崎 香奈, 吉満 誠, 黒田 純也, et al. 未治療移植非適応多発性骨髄腫に対するMPB療法変法のランダム化第II相試験(JCOG 1105)(Randomized phase II study to optimize MPB in untreated transplant-ineligible myeloma: JCOG1105). 臨床血液. 2018. 59. 9. 1610-1610
-
Shinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, Kenichi Miyamoto, Dai Maruyama, Kazuhito Yamamoto, Yoshifusa Takatsuka, Shigeru Kusumoto, Junya Kuroda, Kiyoshi Ando, et al. Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma. Cancer science. 2018. 109. 5. 1552-1561
-
Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, Takashi Watanabe, Dai Maruyama, Eiji Tanaka, Takayo Suzuki, Tomohiro Kinoshita, Michinori Ogura, Ryuzo Ueda, et al. Clinical significance of an ultra-high sensitive HBsAg assay to diagnosing HBV reactivation using stored samples of a prospective HBV DNA monitoring study in B-cell non-Hodgkin lymphoma patients. HEPATOLOGY. 2017. 66. 1028A-1028A
ｍore...
Education (1)：
Return to Previous Page
